GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (NAS:ANGO) » Definitions » Shiller PE Ratio

AngioDynamics (AngioDynamics) Shiller PE Ratio : (As of Apr. 25, 2024)


View and export this data going back to 2004. Start your Free Trial

What is AngioDynamics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


AngioDynamics Shiller PE Ratio Historical Data

The historical data trend for AngioDynamics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Shiller PE Ratio Chart

AngioDynamics Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 110.52 - - - -

AngioDynamics Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of AngioDynamics's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, AngioDynamics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AngioDynamics's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AngioDynamics's Shiller PE Ratio falls into.



AngioDynamics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AngioDynamics's E10 for the quarter that ended in Feb. 2024 is calculated as:

For example, AngioDynamics's adjusted earnings per share data for the three months ended in Feb. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=-4.67/129.4194*129.4194
=-4.670

Current CPI (Feb. 2024) = 129.4194.

AngioDynamics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201405 -0.030 100.373 -0.039
201408 0.010 100.352 0.013
201411 0.040 99.635 0.052
201502 -0.120 99.032 -0.157
201505 -0.020 100.333 -0.026
201508 -0.020 100.548 -0.026
201511 -0.010 100.135 -0.013
201602 0.020 100.040 0.026
201605 -1.210 101.355 -1.545
201608 0.040 101.617 0.051
201611 0.370 101.829 0.470
201702 0.080 102.779 0.101
201705 -0.300 103.256 -0.376
201708 -0.001 103.587 -0.001
201711 0.010 104.072 0.012
201802 0.370 105.052 0.456
201805 0.060 106.148 0.073
201808 -0.010 106.383 -0.012
201811 0.060 106.338 0.073
201902 0.020 106.649 0.024
201905 1.540 108.048 1.845
201908 -0.030 108.245 -0.036
201911 -0.070 108.519 -0.083
202002 -0.150 109.139 -0.178
202005 -4.100 108.175 -4.905
202008 -0.110 109.662 -0.130
202011 -0.110 109.793 -0.130
202102 -0.090 110.968 -0.105
202105 -0.510 113.576 -0.581
202108 -0.180 115.421 -0.202
202111 -0.210 117.269 -0.232
202202 -0.130 119.703 -0.141
202205 -0.160 123.323 -0.168
202208 -0.330 124.958 -0.342
202211 -0.210 125.607 -0.216
202302 -0.240 126.928 -0.245
202305 -0.540 128.314 -0.545
202308 1.150 129.538 1.149
202311 -0.720 129.548 -0.719
202402 -4.670 129.419 -4.670

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AngioDynamics  (NAS:ANGO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AngioDynamics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of AngioDynamics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioDynamics (AngioDynamics) Business Description

Traded in Other Exchanges
Address
14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.
Executives
Lorinda Burgess director 22 WEST FRONTAG ROAD, NORTHBROOK IL 60093
Karen A Licitra director C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101, SANTA CLARA CA 95050
Michael E Tarnoff director C/O ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Scott Centea officer: SVP/GM, VIT C/O ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Dave Helsel officer: SVP Global Operations and R&D 400 WOOD ROAD, BRAINTREE MA 02184
Laura Piccinini officer: SVP International C/O ANGIODYNAMICS INC., 14 PLAZA DRIVE, LATHAM NY 12110
Stephen A Trowbridge officer: SVP and General Counsel 14 PLAZA DRIVE, LATHAM NY 120110
James C Clemmer director, officer: President and CEO COVIDIEN PLC, 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Wesley Johnson director
Chad Thomas Campbell officer: SVP/GM, Vascular Access 140 POKANOKET PATH, WRENTHAM MA 02093
Warren Jr Nighan officer: SVP Quality and Regulatory ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Richard C Rosenzweig officer: SVP and General Counsel C/O DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Kevin J Gould director 247 WASHINGTON STREET, DUXBURY MA 02332
Brent J. Boucher officer: SVP and GM of Oncology 14 PLAZA DRIVE, LATHAM NY 12110
Michael Greiner officer: EVP and CFO C/O VISTAPRINT, 95 HAYDEN AVENUE, LEXINGTON MA 02421